Stay updated on Tesofensine/Metoprolol in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Tesofensine/Metoprolol in Type 2 Diabetes Clinical Trial page.

Latest updates to the Tesofensine/Metoprolol in Type 2 Diabetes Clinical Trial page
- Check2 days agoChange DetectedAdded Revision: v3.4.3; removed Type 2 diabetes and MedlinePlus Genetics-related topics, and Revision: v3.4.2.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAdded related topic tags 'Type 2 diabetes' and 'MedlinePlus Genetics' to the page to improve indexing and discoverability.SummaryDifference0.2%

- Check30 days agoChange DetectedA new site revision banner 'Revision: v3.4.2' was added, and non-core elements such as Type 2 diabetes topic and MedlinePlus Genetics were removed, along with the prior revision note 'Revision: v3.4.1'. These edits do not alter the study details, eligibility criteria, outcomes, or other critical content presented on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check37 days agoChange DetectedA government funding status notice was added and the page revision updated to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check44 days agoChange DetectedAdded a 'Show glossary' option and a revision note in the footer. Minor label capitalization changes were applied (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data').SummaryDifference0.2%

- Check58 days agoChange DetectedAdded related topics 'Type 2 diabetes' and 'MedlinePlus Genetics' to the page, and removed the 'Revision: v3.3.3' entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Tesofensine/Metoprolol in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tesofensine/Metoprolol in Type 2 Diabetes Clinical Trial page.